Role of Biotechnology and Pharmaceutical Companies in Developing Novel Therapies for Female Sexual Dysfunction

Female sexual disorders have historically been treated with multiple non-medical and off-label medical therapies by a limited number of experienced clinicians. Yet, most therapies have insufficient clinical evidence to support their safety and efficacy. Thus, the development of safe and effective therapies for the treatment of sexual disorders in women is critical to improving the overall management of these conditions, and increasing access to care. The International Society for the Study of Women’s Sexual Health (ISSWSH) supports the role of biotechnology and pharmaceutical companies, and other investigators developing novel therapies for female sexual dysfunction. ISSWSH rejects a “one size fits all” approach to treating female sexual dysfunction due to the multiplicity of biopsychosocial factors that impact sexual health. The concept of personalized medicine, and the availability of multiple therapeutic options are critical in this field.

Save the Date

ISSWSH Annual Meeting 2021

March 5-7, 2021  
Virtual
Registration open for on-demand viewing

ISSWSH Fall Course 2021

October 7-10, 2021   67 days left
DoubleTree Resort - Paradise Valley - Scottsdale, AZ
Visit the Course Website

ISSWSH Annual Meeting 2022

March 3-6, 2022   217 days left
Renaissance Dallas Hotel - Dallas, TX
Visit the Meeting Website

Latest Tweets

Last chance to register for tonight's webinar on PGAD/GPD Region 5 - free registration available online: https://t.co/PVwkmAjQve ISSWSH
A new documentary, @ASexplanation, opens up the convo on #sexed https://t.co/nNPwA3bddS ISSWSH
Join us Monday, July 26 for a special #PGAD Webinar on Region 5 with some incredible presenters - free registration… https://t.co/JbVhuV8Dj9 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow Us

On Twitter
On Facebook
On Instagram